 |
|
Metformin Use May Increase Risk of Pancreatic Cancer in Diabetic Women: An Analysis of the Korean National Health Insurance Service-National Health Screening Cohort Database
Joungyoun Kim, Yoon-Jong Bae, Hee-Taik Kang
Korean J Fam Med. 2022;43(5):327-333. Published online 2022 Sep 20 DOI: https://doi.org/10.4082/kjfm.22.0005
|
|
Citations to this article as recorded by
 Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022
Yikuan Du, Jinfeng Zhu, Zhuoming Guo, Zhenjie Wang, Yuni Wang, Mianda Hu, Lingzhi Zhang, Yurong Yang, Jinjin Wang, Yixing Huang, Peiying Huang, Mianhai Chen, Bo Chen, Chun Yang
Expert Review of Clinical Pharmacology.2024; 17(2): 189. CrossRef Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, Huda Dahman, Samhar Alouch, Ahmad Aljada
International Journal of Molecular Sciences.2024; 25(7): 4083. CrossRef Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus
Jan Bures, Darina Kohoutova, Jan Skrha, Bohus Bunganic, Ondrej Ngo, Stepan Suchanek, Pavel Skrha, Miroslav Zavoral
Cancers.2023; 15(14): 3669. CrossRef
|